CRAVE-NX Trademark

Trademark Overview


On Wednesday, December 30, 2009, a trademark application was filed for CRAVE-NX with the United States Patent and Trademark Office. The USPTO has given the CRAVE-NX trademark a serial number of 77902730. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 21, 2017. This trademark is owned by Generex Pharmaceuticals Inc.. The CRAVE-NX trademark is filed in the Pharmaceutical Products category with the following description:

Glucose spray composition for absorption across oral membranes for raising blood glucose level, energy level and/or weight management
crave-nx

General Information


Serial Number77902730
Word MarkCRAVE-NX
Filing DateWednesday, December 30, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 21, 2017
Registration Number3847423
Registration DateTuesday, September 14, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 29, 2010

Trademark Statements


Goods and ServicesGlucose spray composition for absorption across oral membranes for raising blood glucose level, energy level and/or weight management

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 21, 2017
Primary Code005
First Use Anywhere DateThursday, February 12, 2009
First Use In Commerce DateThursday, February 12, 2009

Trademark Owner History


Party NameGenerex Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5J2G2
CA

Party NameGenerex Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5J2G2
CA

Party NameGenerex Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5J2G2
CA

Trademark Events


Event DateEvent Description
Friday, April 21, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, September 14, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, June 29, 2010PUBLISHED FOR OPPOSITION
Wednesday, June 9, 2010NOTICE OF PUBLICATION
Monday, May 24, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 21, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 21, 2010EXAMINER'S AMENDMENT ENTERED
Friday, May 21, 2010ASSIGNED TO LIE
Friday, May 21, 2010EXAMINERS AMENDMENT MAILED
Thursday, May 20, 2010EXAMINERS AMENDMENT -WRITTEN
Friday, May 14, 2010LETTER OF SUSPENSION MAILED
Thursday, May 13, 2010SUSPENSION LETTER WRITTEN
Wednesday, May 5, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 4, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 4, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, February 3, 2010NON-FINAL ACTION MAILED
Wednesday, February 3, 2010NON-FINAL ACTION WRITTEN
Tuesday, February 2, 2010ASSIGNED TO EXAMINER
Tuesday, January 5, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, January 2, 2010NEW APPLICATION ENTERED IN TRAM